While everyone was preparing to head to Wonderland Miami, the psychedelic space saw a week full of debates! From the FDA’s recommendation to limit psychological support in clinical trials, to debates over the necessity of the ‘trip’ in the psychedelic experience, to whether microdosing’s benefits are influenced by expectancy bias.
Risk adjusted net present value: What is the current valuation of Aquestive Therapeutics’s Epinephrine?
Epinephrine is a small molecule commercialized by Aquestive Therapeutics, with a leading Phase III program in Anaphylaxis.
December 14, 2024